发明名称 Fused heteroaryl derivatives
摘要 The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity.
申请公布号 US7173029(B2) 申请公布日期 2007.02.06
申请号 US20050250782 申请日期 2005.10.14
申请人 IMPERIAL CANCER RESEARCH TECHNOLOGY LTD. 发明人 HAYAKAWA MASAHIKO;KAIZAWA HIROYUKI;MORITOMO HIROYUKI;KAWAGUCHI KEN-ICHI;KOIZUMI TOMONOBU;YAMANO MAYUMI;MATSUDA KOYO;OKADA MINORU;OHTA MITSUAKI
分类号 C07D495/04;A61K31/00;A61K31/517;A61K31/519;A61K31/5377;C07D471/04;C07D471/14;C07D487/04;C07D491/04;C07D491/14;C07D495/14 主分类号 C07D495/04
代理机构 代理人
主权项
地址